Search

Your search keyword '"Genentech Inc. -- Intellectual property"' showing total 601 results
Start Over Descriptor "Genentech Inc. -- Intellectual property"
601 results on '"Genentech Inc. -- Intellectual property"'

1. Patent Issued for Optimized variants of anti-VEGF antibodies (USPTO 12121586)

Subjects
Biological products industry -- Intellectual property, Endothelial growth factors -- Reports, Biological products -- Reports -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies -- Reports, Amino acids -- Intellectual property -- Reports, Antibodies -- Reports, Physical fitness -- Reports, Genentech Inc. -- Intellectual property
Abstract

2024 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2024

2. Researchers Submit Patent Application, 'Stable Anti-Cd79b Immunoconjugate Formulations', for Approval (USPTO 20240325559)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property, Physical fitness, Health
Abstract

2024 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

3. Patent Issued for Methods for preparing antibody drug conjugates (USPTO 12090211)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biopharmaceutics -- Reports -- Methods -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies -- Reports -- Methods, Antibodies -- Reports -- Methods, Physical fitness -- Methods -- Reports, Health
Abstract

2024 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2024

4. High Court refuses interim injunction against Zydus' breast cancer drug

Subjects
Genentech Inc. -- Intellectual property, Perjeta (Medication) -- Prices and rates, Drug therapy, Intellectual property, Prices and rates, Company pricing policy, Pertuzumab, Biotechnology industries -- Intellectual property, Patent infringement, Breast cancer -- Drug therapy, Biotechnology industry -- Intellectual property
Published
2024

5. 'Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof' in Patent Application Approval Process (USPTO 20240262932)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Biological products industry -- Intellectual property, Tyrosine -- Intellectual property, Biotechnology industry -- Intellectual property, Pertuzumab, Health, Women's issues/gender studies
Abstract

2024 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors HARRIS, Reed J. (San Mateo, CA, US); MOTCHNIK, [...]

Published
2024

6. Patent Application Titled 'Ion Exchange Membrane Chromatography' Published Online (USPTO 20240247027)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Chromatography, Biotechnology industry -- Intellectual property, Physical fitness, Health
Abstract

2024 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

7. Patent Issued for Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor for treating solid tumors (USPTO 12016862)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Endothelial growth factors -- Methods, Tumors -- Methods, Biotechnology industry -- Intellectual property, Cancer -- Care and treatment, Health, Women's issues/gender studies
Abstract

2024 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Evangelista, Marie (San Francisco, CA, US), Joo, Stephanie Royer [...]

Published
2024

8. Patent Application Titled 'Methods For Treating Spinal Muscular Atrophy' Published Online (USPTO 20240173325)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Physical fitness -- Methods, Health, Evrysdi (Medication) -- Intellectual property
Abstract

2024 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

9. Patent Issued for Ion exchange membrane chromatography (USPTO 11945837)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Chromatography, Biotechnology industry -- Intellectual property, Physical fitness, Health
Abstract

2024 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2024

10. Patent Application Titled 'Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof' Published Online (USPTO 20230416401)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Biological products industry -- Intellectual property, Biological products -- Intellectual property, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property, Pertuzumab, Health, Women's issues/gender studies
Abstract

2024 JAN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

11. Patent Issued for Deep convolutional neural networks for tumor segmentation with positron emission tomography (USPTO 12115015)

Subjects
Viacom Media Networks -- Intellectual property, Genentech Inc. -- Intellectual property, Diseases, Intellectual property, Reports, Neural network, Positron emission tomography -- Reports, Cable television broadcasting industry -- Intellectual property, Machine learning -- Reports, Biotechnology industries -- Intellectual property, Tumors -- Reports, Artificial neural networks -- Intellectual property -- Reports, PET imaging -- Reports, Neural networks -- Intellectual property -- Reports
Abstract

2024 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Bengtsson, Nils Gustav [...]

Published
2024

12. Patent Issued for Production of proteins in glutamine-free cell culture media (USPTO 12103975)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Glutamine -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Genentech Inc. (South San Francisco, California, United States) has been issued patent number 12103975, according [...]

Published
2024

13. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 12098211)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property, Biopolymers, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Hewitt, Daniel P. (Sunnyvale, CA, US), Kao, Yung-Hsiang (San Mateo, [...]

Published
2024

14. Patent Issued for Anti-hypusine antibodies and uses thereof (USPTO 12099064)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Lysine -- Intellectual property, Biological products -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies, Antibodies, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

16. Researchers Submit Patent Application, 'TREATMENT OF CANCER USING COMBINATION THERAPIES COMPRISING GDC-6036 and GDC-0077', for Approval (USPTO 20230321102)

Subjects
Genentech Inc. -- Intellectual property, Oncology, Experimental, Women -- Health aspects, Biotechnology industry -- Intellectual property, Cancer -- Care and treatment -- Research, Health, Women's issues/gender studies
Abstract

2023 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DHARIA, [...]

Published
2023

17. Researchers Submit Patent Application, 'NALCN Channel Protein and Modulators Thereof', for Approval (USPTO 20240295565)

Subjects
Biological products industry -- Intellectual property, Biochemistry, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property, Genentech Inc. -- Intellectual property
Abstract

2024 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Chua, Han [...]

Published
2024

18. Patent Issued for Multispecific antigen-binding proteins (USPTO 12053525)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Binding proteins, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property, Antigens, Business, Health
Abstract

2024 AUG 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent by the inventors Carter, Paul (Hillsborough, CA, US), Corn, Jacob (Berkeley, [...]

Published
2024

19. Researchers Submit Patent Application, 'Methods Of Treating Lung Cancer With A Pd-1 Axis Binding Antagonist, A Platinum Agent, And A Topoisomerase Ii Inhibitor', for Approval (USPTO 20240261399)

Subjects
Genentech Inc. -- Intellectual property, Oncology, Experimental -- Methods, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property -- Methods, Cancer -- Care and treatment -- Research, Lung cancer -- Methods, Palladium -- Methods -- Intellectual property, Business, Health, Health care industry
Abstract

2024 AUG 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors LOPEZ-CHAVEZ, Ariel [...]

Published
2024

20. 'Methods Of Treating Lung Cancer With A Pd-1 Axis Binding Antagonist, An Antimetabolite, And A Platinum Agent' in Patent Application Approval Process (USPTO 20240252632)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Antineoplastic agents -- Intellectual property -- Methods, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property -- Methods, Lung cancer -- Methods, Palladium -- Methods -- Intellectual property, Antimitotic agents -- Intellectual property -- Methods, Biotechnology industry, Biological sciences, Business
Abstract

2024 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors CHEN, Daniel ShinYu (South San Francisco, CA, US); [...]

Published
2024

22. Researchers Submit Patent Application, 'Combined Transposon-Mediated Integration And Targeted Integration Of Nucleic Acids Into Host Cells', for Approval (USPTO 20240240156)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Transposons, Nucleic acids, Biotechnology industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Barnard, Gavin [...]

Published
2024

23. Patent Issued for Anti-polyubiquitin antibodies and methods of use (USPTO 12037385)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biological products -- Reports -- Methods -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies -- Reports -- Methods, Amino acids -- Intellectual property -- Methods -- Reports, Antibodies -- Reports -- Methods, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Dixit, Vishva (Los [...]

Published
2024

24. Researchers Submit Patent Application, 'Acyclic Oxazepine Compounds Comprising A 6-Aza Moiety And Uses Thereof', for Approval (USPTO 20240228512)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Business, Health, Health care industry
Abstract

2024 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors RAVETZ, Benjamin [...]

Published
2024

25. Patent Issued for Production of heteromultimeric proteins using mammalian cells (USPTO 12030926)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Monoclonal antibodies, Business, Health, Health care industry
Abstract

2024 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Genentech Inc. (South San Francisco, California, United States) has been issued patent number 12030926, according [...]

Published
2024

26. Researchers Submit Patent Application, 'Cysteine Engineered Antibodies and Conjugates', for Approval (USPTO 20240218050)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biological products -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies, Thiols -- Intellectual property, Antibodies, Cysteine, Business, Health, Health care industry
Abstract

2024 JUL 23 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Bhakta, Sunil [...]

Published
2024

27. Patent Issued for Synthetic controls for immunohistochemistry (USPTO 12019069)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Immunohistochemistry, Biotechnology industry -- Intellectual property, Business, Health
Abstract

2024 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2024

28. 'Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof' in Patent Application Approval Process (USPTO 20240207400)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biological products -- Intellectual property, Biotechnology industry -- Intellectual property, Pertuzumab, Health
Abstract

2024 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent application by the inventors ADLER, Michael (Lorrach, DE); GRAUSCHOPF, Ulla (Riehen, CH); MAHLER, [...]

Published
2024

29. Patent Issued for PH adjustment to improve thaw recovery of cell banks (USPTO 12016328)

Subjects
Genentech Inc. -- Intellectual property, Banks (Finance) -- Intellectual property -- Reports, Biotechnology industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Calhoun, Kara (South [...]

Published
2024

30. Patent Issued for Methods of using anti-CD79b immunoconjugates (USPTO 12016842)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Antineoplastic agents -- Reports -- Intellectual property -- Methods, Biotechnology industry -- Intellectual property, Ofatumumab -- Methods -- Intellectual property -- Reports, Amino acids -- Intellectual property -- Reports -- Methods, Antimitotic agents -- Reports -- Intellectual property -- Methods, Health
Abstract

2024 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Chu, Yu-Waye (Burlingame, [...]

Published
2024

31. Patent Issued for Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5) (USPTO 12006360)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biological products -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Interleukins -- Intellectual property, Antibodies, Biopolymers, Business, Health
Abstract

2024 JUL 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent by the inventors Fuh, Germaine (Pacifica, CA, US), Koenig, Patrick (San [...]

Published
2024

32. Patent Issued for Cell-based assay for detecting anti-CD3 homodimers (USPTO 12007398)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, T cells, Biotechnology industry -- Intellectual property, Viral antibodies, Antigens, Antibodies, Business, Health
Abstract

2024 JUL 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- Genentech Inc. (South San Francisco, California, United States) has been issued patent number [...]

Published
2024

33. Patent Application Titled 'Method for Enriching Extracellular Vesicles From Biological Fluid Samples' Published Online (USPTO 20230204588)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Biological products industry -- Intellectual property, Glycoproteins -- Methods, Biotechnology industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2023

34. Patent Issued for Diagnostic and therapeutic methods for the treatment of breast cancer (USPTO 11676731)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Biotechnology industry -- Intellectual property, Estrogen -- Antagonists, Cancer -- Care and treatment, Breast cancer -- Methods, Fulvestrant -- Intellectual property -- Methods, Health, Women's issues/gender studies
Abstract

2023 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2023

35. Patent Application Titled 'Combination Therapies For Treatment Of Breast Cancer' Published Online (USPTO 20230088701)

Subjects
Genentech Inc. -- Intellectual property, Women -- Health aspects, Antineoplastic agents -- Intellectual property, Biotechnology industry -- Intellectual property, Cancer -- Care and treatment, Breast cancer, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2023

36. Invalidity Of A Patent Claiming Antibodies Characterized By Their Function In View Of Amgen

Subjects
Baxalta Inc. -- Intellectual property, Amgen Inc. -- Intellectual property, Genentech Inc. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Prothrombin complex concentrate -- Intellectual property, Hemophilia, Antibodies, Blood coagulation factor VIII, Business, international
Abstract

Baxalta Inc. and Baxalta GmbH (Baxalta) appealed a district court decision that the claims of U.S. Patent No. 7,033,590 were invalid for lack of enablement. The Federal Circuit (the Court) [...]

Published
2024

37. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11999791)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Biopolymers, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

38. Patent Issued for Therapeutic compounds (USPTO 11993599)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Business, Health, Health care industry
Abstract

2024 JUN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

39. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11987637)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Biopolymers, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

40. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11987638)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Biopolymers, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

41. Researchers Submit Patent Application, 'Process For The Preparation Of Benzoxazepin Oxazolidinone Compounds', for Approval (USPTO 20240166595)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Business, Health, Health care industry
Abstract

2024 JUN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Angelaud, Remy [...]

Published
2024

42. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11976127)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Biopolymers -- Reports, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Hewitt, Daniel P. [...]

Published
2024

43. Patent Issued for Pharmaceutical compositions comprising Akt protein kinase inhibitors (USPTO 11969426)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Protein kinases, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Genentech Inc. (South San Francisco, California, United States) has been issued patent number 11969426, according [...]

Published
2024

44. 'Composition And Methods For Stabilizing Liquid Protein Formulations' in Patent Application Approval Process (USPTO 20240123066)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property -- Methods, Biotechnology industry, Biological sciences, Business
Abstract

2024 MAY 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors DEMEULE, Barthelemy Luc (South San Francisco, CA, US); [...]

Published
2024

46. Researchers Submit Patent Application, 'Methods Of Using Anti-Cd79b Immunoconjugates To Treat Diffuse Large B-Cell Lymphoma', for Approval (USPTO 20240115718)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biotechnology industry -- Intellectual property, Non-Hodgkin's lymphomas -- Methods, Amino acids -- Intellectual property -- Methods, Bendamustine -- Methods, Health, Health care industry
Abstract

2024 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- From Washington, D.C., NewsRx journalists report that a patent application by [...]

Published
2024

47. Patent Issued for Azaindoles as inhibitors of HPK1 (USPTO 11944606)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Business, Health
Abstract

2024 APR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent by the inventors Chan, Bryan (Foster City, CA, US), Gancia, Emanuela [...]

Published
2024

48. Researchers Submit Patent Application, 'Anti-Ubiquitination Antibodies And Methods Of Use', for Approval (USPTO 20240109958)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Post-translational modification -- Methods, Biological products -- Methods -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies -- Methods, Ubiquitin -- Methods, Amino acids -- Intellectual property -- Methods, Antibodies -- Methods, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DAVIES, Christopher [...]

Published
2024

49. 'Bioanalytical Analysis Of Site-Specific Antibody Drug Conjugates' in Patent Application Approval Process (USPTO 20240110909)

Subjects
Genentech Inc. -- Intellectual property, Biological products industry -- Intellectual property, Biopharmaceutics -- Intellectual property, Biotechnology industry -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Drug approval, Antibodies, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors Darwish, Martine (San Francisco, CA, US); Kaur, Surinder (Lafayette, [...]

Published
2024

50. Patent Application Titled 'Tumor Phenotype Prediction Using Genomic Analyses Indicative Of Digital-Pathology Metrics' Published Online (USPTO 20240105283)

Subjects
Genentech Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Immunotherapy, Cancer -- Care and treatment, Anopheles, Business, Health, Health care industry
Abstract

2024 APR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results